What we did
Capitalmind actively advised Sofiprotéol on the deal structure, ensuring that it fit its corporate culture and the relevant regulatory constraints of the ACPR, while also offering an attractive transaction for investors.
Capitalmind supported Sofiproteol throughout the fundraising process: drafting the marketing and financial documentation, coordinating interactions with more than 10 different investors, driving the due diligence process, negotiating the final legal documentation and supporting deal execution up to closing on the timeline required by Sofiprotéol.
About the deal
Sofiprotéol, the evergreen growth and buy-out investment vehicle of the AVRIL Group, has announced the completion of a €100 million round of equity funding. This latest fund raising will provide Sofiprotéol with additional resources to carry out its mission to support companies in the French and European Food & Agro sectors, using minority stake-holdings and loans.
Sofiprotéol will now be able to invest up to €60 million per company (as opposed to €50 million before the operation), providing additional investment capabilities in its core targeted sectors – notably in seeds, agricultural supplies, agro-environment, animal nutrition & health, genetics, ingredients, meat processing, food consumer goods, and agro-technologies.
The additional equity has been provided by most of Sofiprotéol’s historical partners – Crédit Agricole, Natixis, Unigrains, Terres Univia, the French Association for Oilseed Seed Producers, the National Federation of Seed Growers, the Federation of Agricultural Traders, the French Association of Oilseed Processors, and the National Association for the Animal Feed Industry. Two French institutional investors, Arkéa and Groupama, have also joined the funding as new partners.